An open-label, low interventional clinical study investigating error rates (critical and overall) prior to any retraining in correct use of the ELLIPTA dry powder inhaler (DPI) compared to other DPIs including; DISKUS, Turbuhaler, HandiHaler and Breezhaler as a monotherapy or in combination, in adult patients with Chronic Obstructive Pulmonary Disease (COPD) (study 204981)
Completed
- Conditions
- chronic obstructive airways disease (COPD)10038716
- Registration Number
- NL-OMON46129
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 360
Inclusion Criteria
* *40 years of age.
* COPD.
* Currently receiving maintenance therapy with one of the treatments listed in table 1 of the protocol (page 17-18).
Exclusion Criteria
* Asthma.
* Participants who have been trained during participation in any device study in the 6 months prior to entry into this study
* Drug/alcohol abuse.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The percentage of participants making at least one critical error at V1 for<br /><br>each DPI tested.</p><br>
- Secondary Outcome Measures
Name Time Method <p>The percentage of participants making at least one critical error at V2 for<br /><br>each DPI tested. The percentage of participants making at least one critical or<br /><br>overall error at V2 for each DPI tested. </p><br>